Rheumatology

EULAR has updated its recommendations for systemic sclerosis, incorporating four new therapies presented at its congress in 2024.

The EULAR 2024 congress stressed the importance of supporting transitions from paediatric to adult care to maintain effective treatment for young patients

A study reveals the significant comorbidities linked to osteoarthritis, highlighting the necessity for enhanced management and patient care strategies.

A study presented at EULAR 2024 aimed to investigate the relationship between large-scale pre-diagnostic proteomics and the risk of incident gout in a nationwide prospective cohort.

Research presented at EULAR 2024 aimed to evaluate the prevalence of anti-Ro/SSA antibodies in the largest available cohort of established systemic sclerosis patients.

A recent study highlights the importance of early diagnosis in psoriatic arthritis patients, showing that shorter delays lead to better clinical outcomes.

Recent study highlights sex differences in disease activity measures and treatment responses among patients with axial spondylarthritis

A new blood test has successfully predicted risk of knee osteoarthritis eight years before signs of the disease appeared on X-rays.